Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Morphine (substance) |
Is a |
True |
Morphinan opioid |
Inferred relationship |
Some |
|
Nalbuphine (substance) |
Is a |
True |
Morphinan opioid |
Inferred relationship |
Some |
|
Poisoning by dihydrocodeine |
Causative agent |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Intentional dihydrocodeine overdose (disorder) |
Causative agent |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Morphinan opioid poisoning |
Causative agent |
True |
Morphinan opioid |
Inferred relationship |
Some |
1 |
Accidental codeine poisoning |
Causative agent |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Intentional poisoning by codeine |
Causative agent |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
forgiftning med codein, uvist med hvilken hensigt |
Causative agent |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Accidental poisoning by dihydrocodeine |
Causative agent |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Intentional poisoning by dihydrocodeine |
Causative agent |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
forgiftning med dihydrocodein, uvist med hvilken hensigt |
Causative agent |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Morphinan opioid adverse reaction |
Causative agent |
True |
Morphinan opioid |
Inferred relationship |
Some |
1 |
Codeine adverse reaction |
Causative agent |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Dihydrocodeine adverse reaction |
Causative agent |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Allergy to morphinan opioid |
Causative agent |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Allergy to codeine |
Causative agent |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Allergy to dihydrocodeine (finding) |
Causative agent |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Morphinan opioid overdose |
Causative agent |
True |
Morphinan opioid |
Inferred relationship |
Some |
1 |
Overdose of codeine |
Causative agent |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Accidental overdose by codeine |
Causative agent |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Intentional overdose by codeine |
Causative agent |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
overdosis af codein, uvist med hvilken hensigt |
Causative agent |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Overdose of dihydrocodeine |
Causative agent |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Accidental overdose by dihydrocodeine |
Causative agent |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
overdosis af dihydrocodein, uvist med hvilken hensigt |
Causative agent |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Codeine phosphate [gastro-intestinal use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
codeinphosphatprodukt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Codeine phosphate 15mg/5mL linctus |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Codeine phosphate 15mg/5mL diabetic linctus |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
codeinphosphat mikstur til børn a 3 mg/5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
codeinphosphat sukkerfri mikstur a 15 mg/5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Codeine phosphate [analgesic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Codeine phosphate 15 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Codeine phosphate 30 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Codeine phosphate 60 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
codeinphosphat 25 mg/5 ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
codeinphosphat 60 mg/ml injektionsvæske, opløsning, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
codeinphosphatpulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Hydromorphone hydrochloride 1.3 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Hydromorphone hydrochloride 2.6 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
hydromorphonhydrochlorid 2 mg kapsel med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
hydromorphonhydrochlorid kapsel med modificeret udløsning a 4 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
hydromorphonhydrochlorid kapsel med modificeret udløsning a 8 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
hydromorphonhydrochlorid kapsel med modificeret udløsning a 16 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
hydromorphonhydrochlorid kapsel med modificeret udløsning a 24 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Product containing morphinan opioid (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Morphinan opioid |
Inferred relationship |
Some |
1 |
Codeine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
codeinmikstur |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Codeine-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Hydromorphone hydrochloride 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
hydromorphonhydrochlorid 5 mg/5 ml oral væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Product containing precisely hydromorphone hydrochloride 3 milligram/1 each conventional release rectal suppository (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
bromazin + codein 12,5 mg/5 ml/10 mg/5ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
brompheniraminmaleat + codeinphosphat + phenylpropanolaminhydrochlorid 2 mg/5 ml 10 mg/5 ml 12,5 mg/5 ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
hydromorphonhydrochlorid 1 mg/ml injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
hydromorphonhydrochlorid 2 mg/ml injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
hydromorphonhydrochlorid 4 mg/ml injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
hydromorphonhydrochlorid 10 mg/ml injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Hydromorphone hydrochloride 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Hydromorphone hydrochloride 4 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Hydromorphone hydrochloride 8 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
hydromorphonhydrochlorid 100% pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Hydromorphone hydrochloride 3 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
hydromorphonhydrochlorid 1 mg/ml væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
hydromorphonhydrochlorid 250 mg pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
codeinphosphat 4,56 mg/ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
codeinphosphat 5 mg/ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
paracetamol 120 mg + alkohol 7%v v + codeinphosphat 12 mg eliksir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
paracetamol 120 mg + codeinphosphat 12 mg suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Product containing precisely codeine phosphate 15 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Codeine phosphate 30 mg and paracetamol 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Product containing precisely codeine phosphate 60 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
codeinphosphat 10 mg + promethazinhydrochlorid 6,25 mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
codeinphosphat 10 mg + pseudoephedrinhydrochlorid 30 mg + triprolidinhydrochlorid 1,25 mg væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Buprenorphine (substance) |
Is a |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Diamorphine (substance) |
Is a |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
codeinphosphat 30 mg/1 ml injektion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Poisoning caused by codeine (disorder) |
Causative agent |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
hydromorphonhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Product containing codeine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg and paracetamol 325 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Aspirin 325 mg and carisoprodol 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Product containing aspirin and carisoprodol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
acetylsalicylsyre + butalbital + caffein + codeinphosphat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
paracetamol + alkohol + codeinphosphat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
paracetamol + butalbital + caffein + codeinphosphat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
acetylsalicylsyre + carisoprodol + codeinphosphat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
codeinphosphat + promethazinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Product containing bromazine and codeine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
brompheniraminmaleat + codeinphosphat + phenylpropanolaminhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
codeinphosphat + pseudoephedrinhydrochlorid + triprolidinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
codeinphosphat 10 mg/10 ml + kaolin 3 g/10 ml mikstur |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Codeine phosphate 60 mg and paracetamol 1 g effervescent powder for oral suspension sachet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Codeine phosphate 30 mg and paracetamol 500 mg effervescent oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Codeine phosphate 30 mg and paracetamol 500 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Product containing precisely codeine phosphate 13.5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|
Codeine phosphate 12.8 mg and paracetamol 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Morphinan opioid |
Inferred relationship |
Some |
|